INDEMNIFICATION AGREEMENTIndemnification Agreement • May 15th, 2019 • Xynomic Pharmaceuticals Holdings, Inc. • Pharmaceutical preparations • Delaware
THIS INDEMNIFICATION AGREEMENT (the “Agreement”) is made and entered into as of May 15, 2019 between Xynomic Pharmaceuticals Holdings, Inc., a Delaware corporation (the “Company”), and __________ (“Indemnitee”).
ESCROW AGREEMENTEscrow Agreement • May 15th, 2019 • Xynomic Pharmaceuticals Holdings, Inc. • Pharmaceutical preparations • New York
This ESCROW AGREEMENT (this “Agreement”) is made and entered into as of May 13, 2019, by and among: (i) Bison Capital Acquisition Corp., a British Virgin Islands company which, prior to the consummation of the transactions contemplated by the Merger Agreement (as defined below), will domesticate as a Delaware corporation and, immediately thereafter will be known as “Xynomic Pharmaceuticals Holdings, Inc.” (“Parent”), (ii) Yinglin Mark Xu, solely in his capacity under the Merger Agreement as the Stockholder Representative (the “Stockholder Representative”); and (iii) Continental Stock Transfer & Trust Company, as escrow agent (the “Escrow Agent”). Capitalized terms used herein but not defined herein shall have the meanings given to such terms in the Merger Agreement (as defined below).
AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • May 15th, 2019 • Xynomic Pharmaceuticals Holdings, Inc. • Pharmaceutical preparations • New York
THIS AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is entered into as of May 15, 2019, by and among Bison Capital Acquisition Corp., a Delaware corporation, which will be known after the consummation of the transactions contemplated by the Merger Agreement as “Xynomic Pharmaceuticals Holdings, Inc.” (the “Company”), Bison Capital Holding Company Limited, a company incorporated in the Cayman Islands (the “Sponsor”), each of the undersigned parties listed under “Existing Investors” on Exhibit A hereto, each of which holds Existing Registrable Securities (collectively, with the Sponsor, the “Existing Investors”), Yinglin Mark Xu (togeher with his assignee, the “Backstop Investor”), and the undersigned parties listed under “New Investors” on Exhibit A hereto (each, a “New Investor” and collectively, with the Existing Investors and the Backstop Investor, the “Investors”). This Agreement shall become effective upon the Closing (as defined hereinafter). Any capitalized
